chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymph mode; Tender; Sudden mass (ganglion?) above left collar bone; Sore; This is a spontaneous report from a contactable consumer, the patient. A 41-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 27Mar2021 at 11:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient had no known allergies to medications, food, or other products were reported. Concomitant medications included VIT D3 (MANUFACTURER UNKNOWN) 50000 IU one per week, from unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 17:00 the patient experienced swollen lymph node, neck mass, sudden mass (ganglion) above left collar bone, sore and tenderness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the swollen lymph node, neck mass, sore and tenderness was not recovered.  No follow-up attempts are needed. No further information is expected.
I experienced fever, aches, nausea, joint pain. Developed 4 days after vaccine, a rash 3in; a flat hive, very itchy on left arm below injection site above the elbow.
Client received the 1st COVID vaccine (Pfizer for ages 5-11 Lot #FL0007 expiration 3-1-2022 at 1419). Client arrived to observation area at 1430. At 1435, clients mother alerted EMT, LPN of clients headache. LPN escorted client and her mother to gravity chair, and client sat down. PHN and PHN responded at 1438. Client reports dizziness and headache. Clients vital signs at 1438: BP 108/63, HR 78, o2 99% and respirations 16. Pt was given water and then was reclined on chair by PHN. At this time, clients mother stated that client has had a headache for weeks and currently has a covid test pending. Clients mother further states that she fainted recently, and her pediatrician is aware. Per pediatrician, client is to limit exercise and hydrate. At 1445, client states her headache is down to a 2/10 on pain scale. At this time, PHN is already on the phone with EMS for a different client and PHN informs client mother of the need for EMS. Clients mother states that she will be refusing EMS for client. Client states that her dizziness and headache have both resolved at 1503. PHN reviewed ER precautions with clients mother and recommended to follow up with pediatrician as soon as possible. Client left with mother at 1505 in stable condition with stable gait prior to EMS arriving.
Info has been received from a consumer and his wife concerning their son's pediatrician, ad adult male, who "recently" in approx 2002 was vax'd w/a dose of Hep B vax recombinant. It was reported that he experienced "bad reactions to the shot". The reporter indicated that the PT told him about the reactions, but did not go into detail. It was reported that it "sounded like" his muscles became rigid. He was also "bewildered and thought he might have a brain tumor until he realized his Sx's were a reaction to the shots." No add'l info was provided. The consumer reported this episode upon providing follow-up info, reporting his son who developed "severe adverse effects" following vax w/Hep B vax recombinant. Add'l info is not expected.
Site of injection was hard and swollen, sore like a size of a silver dollar happened on Sunday (8/18/13) 2 days after inj. Put only ice every 10 min (4 x a day). 8/21/13 better but still a size of a quarter. Flat and warm.
The rash  is described by mother as small red bumps which appeared the next day after vaccines. Mother believes that patient develops a rash "everytime" she gets vaccines. Papular rash noted on right extremities at exam.
12x13cm red area at site.  Left arm very swollen and painful.  Afebrile.  Reported another today from same vial.  Saved vial.
pt recvd vax & found in crib 5PM less responsive & not feeling well; mom also noted @ the same time @ 5PM that eyes were rolling & hands were moved inside & there was some shaking; called 911 & by the time that the 911; t103 advised mom ER;
Swollen lymph nodes under arm, small red, dry area on arm, pimple style sores
Fatigue starting approx. 12 hours after second pfizer covid vaccine shot and lasting 24 hours; reduced appetite; fever from approx 24 hours after shot (maybe sooner) until approx. 36 hours after shot.  Highest recorded temp was 102.2 at approx. 30 hours after shot.   Fatigue interfered with daily activities from 12 hours after shot to 36 hours after shot.  Mild soreness in arm where shot was given.   Pulse and blood oxygen were checked each time temp was taken (approx 3 times between 24 and 36 hours after shot) and were within normal ranges each time; although pulse was on the higher end of the normal range for a 12 year old boy.  Quick recover starting 36 hours after shot, when temp reduced to approx. 100.  Appetite returned at this time.  Fever was gone by 48 hours after shot and all other side effect seemed to have subsided by this point.  No mediation was taken by the vaccine recipient.  Vaccine recipient was offered usual foods and he consumed milk and water in smaller amounts than usual but also more frequently than usual to stay hydrated.
most people have more side effects with the second dose; This case was reported by a consumer and described the occurrence of adverse drug reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not applicable for this report. The pharmacist told to the reporter that most people have more side effects with the second dose of Shingrix. This case has been linked with case US2020AMR033844 and US2020AMR041746, reported by same reporter.
Meningoccal B was inadvertently administered to under age 16 in a healthly child.
Mother noted Left upper arm was swollen, red, and warm to the touch 24 hours after shots received. Child saw Dr 4-15-09. Nurse noted redness and swelling of left upper ext down to pt elbow. Area was warm to the touch, but child not complaining of much pain. No fever or chills. Treatment given was antibiotic and steriod. Mother to call if area does not improve.
fatigue, severe joint pain, headache, nausea, affected sense of smell, body aches
taken to ER p/displaying fever of 103 ax & mom noticed episode sl cyanosis, jerking of arm & legs, & eyes rolling back all last 1-1 1/2min;had fever x 24hrs;given APAP 1115AM;
Patient received the 1st dose 56 days ago; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received the 1st dose 56 days ago) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received the 1st dose 56 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient received the 1st dose 56 days ago) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NS follow up append
soreness where she shot me; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness where she shot me) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness where she shot me). On 30-Mar-2021, VACCINATION SITE PAIN (soreness where she shot me) had resolved.            This case was linked to MOD-2021-033469 (Patient Link).
Vomited 3x about 10-15 minutes after receiving 2nd Hepatitis B vaccine.  Continued to feel sick and had to leave work early.
Chills; Tiredness; Mild soreness at injection site; Headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 13Mar2021 12:00 (Lot number: EN6207) at the age of 60 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Overweight" (ongoing), notes: Verbatim: Overweight, A few years maybe 3 years.; "Blood pressure high" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for hypertension (ongoing). The following information was reported: CHILLS (non-serious) with onset 14Mar2021, outcome "recovering", described as "Chills"; HEADACHE (non-serious) with onset 13Mar2021, outcome "recovering", described as "Headache"; FATIGUE (non-serious) with onset 14Mar2021, outcome "not recovered", described as "Tiredness"; VACCINATION SITE PAIN (non-serious) with onset 14Mar2021, outcome "recovering", described as "Mild soreness at injection site". Therapeutic measures were taken as a result of headache, vaccination site pain.  Additional information: Concomitant Products Losartan: Been taking for about a year, Patient has overweight A few years maybe 3 years. Patient has mild soreness at injection site is a little but tender to touch.Investigation Assessment was no.Caller reported having adverse events to COVID 19 vaccine. Treatment was  Drank a lot of water, hydrating constantly, and bed rest. History of all previous immunization with the Pfizer vaccine considered as suspect was none.Additional Administered Vaccines was none.The patient did not visited  to Emergency Room.Prior Vaccinations (within 4 weeks) was none.Relevant Tests was none.the patient taking COVID 19 vaccine (Verbatim): Two comorbidities.  No follow-up attempts are possible. No further information is expected.
Expired dose administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Patient experience facial swelling, lip swelling, and hives on the back of the head. Patient stated she did not feel like she had any trouble breathing. Patient was advised to take Benadryl or Claritin and follow up with PCP if symptoms did not resolve. Upon follow-up several days later, patient stated that all her symptoms had resolved.
Description: 22 y/o male SM receives AVA #1 in preparation for upcoming deployment out of country. SM reports the eruption of  hive-like skin rash and pruritus 4-5 hours after the receipt of the AVA vaccine. Symptom: Rash, diffuse Start: 09/25/2007 Comment: Developed 4-5 hours after AVA #1. The rash involved the chest, back, arms, legs. Symptom: Pruritus Start: 09/25/2007 Comment: The rash was pruritic in the skin rash areas. the member also reported itching at the roof of his mouth. Symptom: Hives Start: 09/25/2007 Comment: Rash is described as an eruption of hives. Symptom: Erythema Start: 09/25/2007 Comment: the rash was described as 'red blotches.'
Vaccine was administered to a minor under the age of 18 years of age due to administration error.  As of May 10th, 2021 the Moderna Covid vaccine is only indicated for adults aged 18 years and older.  No adverse events were reported by the patient.
Developed hives on elbow and knee joints. Some shortness of breath. Treated with inhaler and Benadryl.
First aches in prior injury sites: Right Rotator Cuff ( surgery 1989) Lumbar spine ( strains off/on) left 5th MTP ( fracture 2014)   Progressed to general malaise with increased pain at left midfoot and 5th MTP along with lateral ankle pain. No recent trauma to any areas noted.  Currently still suffer from lack of energy and intermittent left foot pain.
The physician did note that this events was unlike he experienced using Shingrix previously; This case was reported by a physician via sales rep and described the occurrence of adverse drug reaction in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The physician did note that this events (experienced by the patient) was unlike he experienced using Shingrix previously. Consented to follow up. This case is linked to the case US2020034226, reported by the same reporter for different patient.
painful blistering rash and continued thereafter to suffering from nerve pain once rash resolved.; painful blistering rash and continued thereafter to suffering from nerve pain once rash resolved.; Information has been received from a lawyer regarding a case in litigation and refers to a female patient (pt) of an unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 12-SEP-2012, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, dose number, route, anatomical site of vaccination, lot number and expiration date were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date (reported as shortly after receiving zoster vaccine live (ZOSTAVAX)), the pt suffered from a painful blistering rash and continued thereafter to suffer from nerve pain once rash resolved. As a result of these symptoms, pt was seen and treated by medical providers, who diagnosed her with shingles (herpes zoster) and post-herpetic (post herpetic neuralgia). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, pt's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). She also experienced mental and emotional distress due to resulting physical limitations and seriousness of pt's condition. Pt sustained severe and permanent personal injuries. Pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of herpes zoster and post herpetic neuralgia was not recovered. The reporter assessed that the events were related to zoster vaccine live (ZOSTAVAX).  Herpes zoster and post herpetic neuralgia have been considered disabling events by the reporter.
Information has been received from a physician concerning a 13 year old female who, on an unspecified date, was vaccinated intramuscularly with a second dose of Gardasil. Within 24-48 hours, the patient experienced fever, achiness and diarrhea. The physician reported that 1-2 days later, the patient developed blood in the stool and was admitted to the hospital. The physician reported that the patient was diagnosed with acute kidney failure and was still hospitalized. At the time of this report, the patient's fever, achiness and acute kidney failure persisted. Fever, achiness and acute kidney failure were considered to be immediately life-threatening and disabling. Additional information has been requested.    5/18/07 Received medical records from hospital which reveal patient seen at hospital 3/18-3/26/07 for nausea, vomiting, bloody diarrhea & fever starting approx 3/11/07.  Found to have asymptomatic E.coli UTI that traveled to kidneys.  Treated w/IV antibiotics & started on dialysis & placed on kidney transplant list. Progressed well & d/c to home on oral antibiotics.  FINAL DX: acute renal failure, urosepsis, polycystic kidney disease, end stage renal failure, hemodialysis.  3/27-4/2/07 - Re-Admitted to pediatric nephrology with fever, dizziness & orthostasis.  Treated w/multiple IV antibiotics.  Was to continue dialysis but at least 2 sessions cancelled due to hypotension.  Outpatient hemodialysis was arranged closer to her home & was to continue IV antibiotics at dialysis center as well as continue on oral antibiotics.  Plan was to transition to peritoneal dialysis after off antibiotics for 1 week. FINAL DX: posible partially treated urosepsis; end stage renal disease; polysystic kidney disease; rotavirus gastroenteritis; h/o acute renal failure.  4/25/07  Seen in Dialysis at outlying center.  Doing well, last dose of antibiotics on 4/13 & afebrile since then.  Labs were much improved & a trial of decreased dialysis was discussed.  5/4/07 - Seen in surgery clinic for evaluation of peritoneal dialysis catheter for acute renal failure superimposed on chronic renal failure.  HD site noted to possibly be infected & was started on oral antibiotics.  Repeat stool & urine tests ordered & scheduled for PD placement.  5/7/07 MRI of brain was WNL.  6/22/07 Received medical records & vax record from reporter/provider which reveal patient received HPV on 3/14/07 & was 1st dose.  VAERS database updated w/same.  Medical records of 1994-2004.
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: Swelling of the face on second shot. Pt's dr said it may be an immune response to the vaccine causing swelling in the face near the eye
5 days after first dose I had my first ever UTI. 4 days after second dose I experienced severe dry cough with some difficulty breathing, a fever ranging from 99.5-102 which lasted for 6 days, increased joint and muscle pain, severe nausea lasting 10 days with weight loss of 7 pounds. 4 visits to Urgent Care and one ER visit
The J and J vaccine was administered at  University to students and my son on 4/9/21 at 11am. Seven hours after receiving the injection (6pm) my son came home from work with a temperature of 101.7F and body aches.  On Saturday 4/10/21 my son was still running a temperature of 99.1F at noon, 100.9F at 5pm.  On Sunday morning 4/11/21 his temperature was gone, but he continued to feel tired the next few days.
Muscle pain, tired, weak, achy throughout body, shivering hot and cold, upset stomach, taste of medicine twice, gas.
Chills, fatigue, dizziness when standing, nose bleeds, cough, hand tremors, cold hands & feet, heart palpitations, brain fog, decreased appetite, loose bowels, putrid bowels. Insomnia, heavy legs, dry rash on face, head arm & legs. Bleed out huge clots from vomiting although he has no clotting g factor from liver damage
On late 11/2022 in the morning I was diagnosed with bladder cancer. I had urgency to urinate and painful urination. My doctor did few tests which  showed  evidence of cancer cells. I just started chemotherapy this week. I will be continuing  it for 6 weeks. I have a follow up  with my doctor in late June. He  will run some more test to see what is happening around. I am taking Oxybutynin 10 milligram  up to  3 pills  a day as of now.
GARDASIL 9, MENACTRA given 2 pm, 2:05 pm. Pt. c/o dizziness, weak. Pt. placed in supine position, cold compress. Vitals taken BP 140/80 pt proceeded to vomit small amt. mucus. BP at 2:15 150/90, pulse 106, O2 SAT 98. C/O throat and chest discomfort, examined by MD. Monitored x 30 min. vitals at 2:41 BP 122/86, P92, O2 SAT 97. Felt better, discharged. Called 4 pm and doing well. Will F/U in AM.
Loss of balance (Fell),  Headache,  muscle aches , Incontenence, dry mouth, and Severe chills, fever
ZOSTAVAX vaccination given in error when varicella was ordered by provider. Given at 2:00 pm 4/8/13 with no evident adverse reaction followed up with patient by phone and still no reaction.
burning and cramping in the muscle under the site of vaccination (tricep area), itching on skin, bruising in armpit, pain and swelling on side of the breast, and itchiness in the armpit. All symptoms are exclusively on the side that I received the vaccination.
At 6:00 am on 1/5/2021, I woke up with a swollen face. Took a Benadryl. At 0630 I started vomiting   Some SOB and wheezing   I feel better after vomiting, Benadryl, and inhalers
I felt fine after the injection ( approx 10:45 AM) and during the 30 minutes we were asked to wait.  We drove home, stopping to pick up take-out for lunch,  got home and ate.  I was calmly sitting/reading when around 1:30 PM I started to feel my heart beating rapidly.  Using our home monitor, I checked my BP and HR.  (My usual resting values are 130-135/ 75/80  for BP and 80 for HR.)  My reading was 160/90 and 101; 5 minutes later it was 175/105 and 106; 5 minutes later it was 185/122 and 116.  I started to be quite concerned since it seemed to just keep climbing.  I called EMS and they came by to check on me.  As they had me take deep breaths, it began to go down.  But it took several hours to get back to normal values (@ 8:30 PM  it was finally down to 168/79 and 85).  I had the same reaction with the second vaccine on 3/4/21, but it did not last as long.  It again started about 2 1/2 hours after the shot, but was back to normal by 3:30 PM.